StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a report published on Sunday. The firm issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Stock Performance
Shares of CO stock opened at $1.20 on Friday. The stock has a 50 day moving average of $1.23 and a 200 day moving average of $1.35. The stock has a market cap of $145.86 million, a P/E ratio of 1.88 and a beta of 0.16. Global Cord Blood has a twelve month low of $2.03 and a twelve month high of $5.50.
Global Cord Blood Company Profile
Featured Stories
- Five stocks we like better than Global Cord Blood
- Insider Trading – What You Need to Know
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
- What does consumer price index measure?
- General Mills Q4 Sales Miss Expectations, Triggering Stock Drop
- Why Are Stock Sectors Important to Successful Investing?
- Enovix Stock Rises 35% in Short-Squeeze: This Rally Has Legs
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.